Literature DB >> 15652345

Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells.

Permila C Harrell1, Lisa J McCawley, Barbara Fingleton, J Oliver McIntyre, Lynn M Matrisian.   

Abstract

Matrix metalloproteinase-7 (MMP-7) is primarily expressed in glandular epithelium. Therefore, its mechanism of action may be influenced by its regulated vectorial release to either the apical and/or basolateral compartments, where it would act on its various substrates. To gain a better understanding of where MMP-7 is released in polarized epithelium, we have analyzed its pattern of secretion in polarized MDCK cells expressing stably transfected human MMP-7 (MDCK-MMP-7), and HCA-7 and Caco2 human colon cancer cell lines. In all cell lines, latent MMP-7 was secreted to both cellular compartments, but was 1.5- to 3-fold more abundant in the basolateral compartment as compared to the apical. However, studies in the MDCK system demonstrated that MMP-7 activity was 2-fold greater in the apical compartment of MDCK-MMP-7(HIGH)-polarized monolayers, which suggests the apical co-release of an MMP-7 activator. In functional assays, MMP-7 over-expression increased cell saturation density as a result of increased cell proliferation with no effect on apoptosis. Apical MMP-7 activity was shown to be responsible for the proliferative effect, which occurred, as demonstrated by media transfer experiments, through cleavage of an apical substrate and not through the generation of a soluble factor. Taken together, our findings demonstrate the importance of MMP-7 secretion in relation to its mechanism of action when expressed in a polarized epithelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15652345     DOI: 10.1016/j.yexcr.2004.09.020

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells.

Authors:  Lauren A Thurgood; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2011-09-20

2.  Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis.

Authors:  Hui Liu; Jing Huang; Benquan Wu; Yuqi Zhou; Jiaxin Zhu; Tiantuo Zhang
Journal:  Med Oncol       Date:  2008-03-14       Impact factor: 3.064

3.  Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA.

Authors:  Conor C Lynch; Tracy Vargo-Gogola; Lynn M Matrisian; Barbara Fingleton
Journal:  J Oncol       Date:  2010-06-10       Impact factor: 4.375

4.  Expression and intracellular localization of matrix metalloproteinases in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Urara Tamahashi; Jiro Kumagai; Touichiro Takizawa; Masaki Sekine; Yoshinobu Eishi
Journal:  Virchows Arch       Date:  2008-05-24       Impact factor: 4.064

5.  Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon.

Authors:  Randy L Scherer; Michael N VanSaun; J Oliver McIntyre; Lynn M Matrisian
Journal:  Mol Imaging       Date:  2008 May-Jun       Impact factor: 4.488

6.  An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.

Authors:  Sophie Thiolloy; James R Edwards; Barbara Fingleton; Daniel B Rifkin; Lynn M Matrisian; Conor C Lynch
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

7.  Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma.

Authors:  Fumihiko Urushibara; Eisuke Shiozawa; Hideyuki Miyachi; Masashi Misawa; Tomonari Cho; Yusuke Takehara; Nana Arai; Toshitaka Funaki; Sakiko Tazawa; Mayumi Homma; Tomoko Norose; Mutsuko Omatsu; Toshiko Yamochi; Toshiaki Kunimura; Genshu Tate; Kazuho Honda; Ishida Fumio; Shin-Ei Kudo; Masafumi Takimoto
Journal:  Oncol Lett       Date:  2018-01-08       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.